Chemoprevention by pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats

Japanese Journal of Cancer Research

Volumn 87, Issue 8, 1996, Pages 798-804

  Narisawa, Tomio ^a   Morotomi, Masami ^b   Fukaura, Yoko ^a   Hasebe, Makiko ^a   Ito, Michiko ^a   Aizawa, Rika ^a  

^a AKITA UNIVERSITY   (Japan)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Cancer chemoprevention; Colon cancer; HMG CoA reductase; Pravastatin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; METHYLNITROSOUREA; PRAVASTATIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0029815533     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb02103.x     Document Type: Article

References (43)

1. Quesney-Huneeus, V., Wiley, M. H. and Siperstein, M. D. Essential role for mevalonate synthesis in DNA replication. Proc. Natl. Acad. Sci. USA, 76, 5056-5060 (1979).
2. Casey, P. J., Solski, P. A., Der, C. J. and Buss, T. E. p21 ras is modified by a farnesyl isoprenoid. Proc. Natl. Acad. Sci. USA, 86, 8323-8327 (1989).
3. Schafer, W. R., Kim, R., Sterne, R., Thorner, J., Kim, S.-H. and Rine, J. Genetic and pharmacological suppression of oncogenic mutations in RAS genes of yeast and humans. Science, 245, 379-385 (1989).
4. Goldstein, J. L. and Brown, M. S. Regulation of the mevalonate pathway. Nature, 343, 425-430 (1990).
5. Bennis, F., Favre, G., Gaillard, F. L. and Soula, G. Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549. Int. J. Cancer, 55, 640-645 (1993).
6. Feleszko, W., Lasek, W., Golab, J. and Jakobisiak, M. Synergistic antitumor activity of tumor necrosis factor a and lovastatin against MmB16 melanoma in mice. Neoplasma, 42, 69-74 (1995).
7. Goldstein, J. L., Helgesen, J. A. and Brown, M. S. Inhibition of cholesterol synthesis with compactin renders growth of cultured cells dependent on the low density lipoprotein receptor. J. Biol. Chem., 254, 5403-5409 (1979).
8. Kawata, S., Kakimoto, H., Ishiguro, H., Yamasaki, E., Inui, Y. and Matsuzawa, Y. Effect of pravastatin, a potent 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, on survival of AH130 hepatoma-bearing rats. Jpn. J. Cancer Res., 83, 1120-1123 (1992).
9. Maltese, W. A., Defedini, R., Green, R. A., Sheridan, K. M. and Donley, D. K. Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Clin. Invest., 76, 1748-1754 (1985).
10. Newman, A., Clutterbuck, R. D., Powles, R. L. and Miller, J. L. Selective inhibition of primary acute myeloid leukemia cell growth by lovastatin. Leukemia, 8, 274-280 (1994).
11. Sinensky, M., Beck, L. A., Leonard, S. and Evans, R. Differential inhibitory effects of lovastatin on protein isoprenylation and sterol synthesis. J. Biol. Chem., 265, 19937-19941 (1990).
12. Soma, M. R., Baetta, R., Renzis, R., Mazzini, G., Davegna, C., Magrassi, L., Butti, G., Pezzotta, S., Paoletti, R. and Fumagalli, R. In vivo enhanced antitumor activity of carmustin [N, N'-bis (2-chloroethyl)-N-nitrosourea] by simvastatin. Cancer Res., 55, 597-602 (1995).
13. Sumi, S., Beauchamp, D., Townsend, C. M., Jr., Uchida, T., Murakami, M., Rajaraman, S., Ishizuka, T. and Thompson, J. Inhibition of pancreatic adenocarcinoma cell growth of lovastatin. Gastroenterology, 103, 982-989 (1992).
14. Ura, H., Obara, T., Nishino, N., Tanno, S., Okamura, K. and Namiki, M. Cytotoxicity of simvastatin to pancreatic adenocarcinoma cells containing mutant ras gene. Jpn. J. Cancer Res., 85, 633-638 (1994).
15. Rush, R. J., Madhukar, B. V., Trosko, J. E. and Klauning, J. E. Reversal of ras-induced inhibition of gap-junctional intercellular communication, transformation, and tumorigenesis by lovastatin. Mol. Carcinog., 7, 50-59 (1993).
16. Sebti, S. M., Thalcevic, G. T. and Jani, J. P. Lovastatin, a cholesterol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude mice. Cancer Commun., 3, 141-147 (1991).
17. Brown, M. S., Faust, J. R., Goldstein, J. L., Kaneko, I. and Endo, A. Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. J. Biol. Chem., 253, 1121-1128 (1978).
18. Habenicht, A. J. R., Glomset, A. J. and Russell, R. Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J. Biol. Chem., 255, 5134-5140 (1980).
19. Kaneko, I., Hazama-Shimada, Y. and Endo, A. Inhibitory effects on lipid metabolism in cultured cells of ML-236B, a potent inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase. Eur. J. Biochem., 87, 313-321 (1978).
20. McGuire, T. F., Corey, S. J. and Sebti, S. M. Lovastatin inhibits platelet-derived growth factor (PDGF) stimulation of phosphatidylinositol 3-kinase activity as well as association of p85 subunit to tyrosine-phosphorylated PDGF receptor. J. Biol. Chem., 268, 2227-2230 (1993).
21. Narisawa, T., Fukaura, Y., Terada, K., Umezawa, A., Tanida, N., Yazawa, K. and Ishikawa, C. Prevention of 1,2-dimethylhydrazine-induced colon tumorigenesis by HMG-CoA reductase inhibitors, pravastatin and simvastatin, in ICR mice. Carcinogenesis, 15, 2045-2048 (1994).
22. Narisawa, T., Sato, T., Hayakawa, M., Sakuma, A., Nakano, H. Carcinoma of the colon and rectum of rats by rectal infusion of N-methyl-N'-nitro-N-nitrosoguanidine. Gann, 62, 231-234 (1971).
23. Takahashi, T. and Morotomi, M. Absence of cholic acid 7α-dehydroxylase activity in the strains of Lactobacillus and Bifidobacterium. J. Dairy Sci, 77, 3275-3286 (1994).
24. van Faassen, A., Bol. J., van Dokkum, W., Pikaar, N. A., Ockhuizen, T. and Hermus, R. J. J. Bile acids, neutral sterols, and bacteria in feces as affected by a mixed, a lacto-ovovegetarian, and a vegan diet. Am. J. Clin. Nutr., 46, 962-967 (1987).
25. Fearon, E. R. and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61, 759-767 (1990).
26. Jacoby, R. F., Llor, X., Teng, B. B., Davidson, N. O. and Brasitus, T. A. Mutations in the k-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa. J. Clin. Invest., 87, 624-630 (1991).
27. Jacoby, R. F., Alexander, R. J., Raicht, R. F. and Brasitus, T. A. K-ras oncogene mutations in rat colon tumors induced by N-methyl-N-nitrosouea. Carcinogenesis, 13, 45-49 (1992).
28. Pretlow, T. P., Brasitus, T. A., Fulton, N. C., Cheyer, C. and Kaplan, E. L. K-ras mutations in putative preneoplastic lesions in human colon. J. Nail. Cancer Inst., 85, 2004-2007 (1993).
29. Stopera, S. A., Murphy, L. C. and Bird, R. P. Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Spague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer. Carcinogenesis, 13, 2081-2085 (1992).
30. Crowell, P. L., Ren, Z., Lin, S., Wedejs, E. and Gould, M. N. Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem. Pharmacol, 47, 1405-1415 (1994).
31. James, G. L., Goldstein, J. L., Brown, M. S., Rawson, T. E., Somers, T. C., McDowell, R. S., Crowley, C. W., Lucas, B. K., Levinson, A. D. and Marsters, J. C., Jr. Benzodiazepine peptidomimetics: potent inhibitors of ras farnesylation in animal cells. Science, 260, 1937-1942 (1993).
32. Nagasu, T., Yoshimatsu, K., Rowell, C., Lewis, M. D. and Garcia, A. M. Inhibition of human tumor xenograft growth by treatment with the farnesyl transferase inhibitor B956. Cancer Res., 55, 5310-5314 (1995).
33. Sepp-Lorenzino, L., Ma, Z., Rands, E., Kohl, N. E., Gibbs, J. B., Oliff, A. and Rosen, N. A peptidomimetic inhibitor of farnesyl: protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines. Cancer Res., 55, 5302-5309 (1995).
34. Endo, A., Tsujita, Y., Kuroda, M. and Tanzawa, K. Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals. Biochim. Biophys. Acta, 575, 266-276 (1979).
35. Tsujita, Y., Kuroda, M., Shimada, Y., Tanzawa, K., Arai, M., Kaneko, I., Tanaka, M., Masuda, H., Tarumi, C., Watanabe, Y. and Fujii, S. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim. Biophys. Acta, 877, 50-60 (1986).
36. Rudney, H. and Sexton, R. C. Regulation of cholesterol biosynthesis. Ann. Rev. Nutr., 6, 245-272 (1986).
37. Fujioka, T., Nara, F., Tsujita, Y., Fukushige, J., Fukami, M. and Kuroda, M. The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats. Biochim. Biophys. Acta, 1254, 7-12 (1995).
38. Puppo, D. M., Rauli, S. and Kienle, G. M. Inhibition of cholesterol synthesis and hepatic 3-hydroxy-3-methylglutaryl-CoA reductase in rats by simvastatin and pravastatin. Lipids, 30, 1057-1061 (1995).
39. Narisawa, T., Magadia, N. E., Weisburger, J. H. and Wynder, E. L. Promoting effect of bile acids in colon carcinogenesis after intrarectal instillation of N-methyl-N′-nitro-N-nitrosoguanidine in rats. J. Natl. Cancer Inst., 53, 1093-1097 (1974).
40. Reddy, B. S., Watanabe, K., Weisburger, J. H. and Wynder, E. L. Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res., 37, 3238-3242 (1977).
41. Khan, S. G., Saxena, R., Bickers, D. R., Mukhtar, H. and Agarwal, R. Inhibition of ras p21 membrane localization and modulation of protein kinase C isozyme expression during regression of chemical carcinogen-induced murine skin tumors by lovastatin. Mol. Carcinog., 12, 205-212 (1995).
42. Siperstein, M. D. and Fagan, V. M. Deletion of cholesterol-negative feedback system in liver tumors. Cancer Res., 24, 1108-1115 (1964).
43. Goldfarber, S. and Pitot, H. C. The regulation of β-hydroxy-β-methylglutaryl coenzyme A reductase in Morris hepatomas 5123C, 7800, and 9618A. Cancer Res., 31, 1879-1882 (1971).